Rosemont Pharmaceuticals Limited named as one of the fastest growing PE-backed mid-market businesses over the past three years

Rosemont has been listed as one of the fastest growing private-equity-backed companies in the UK, according to a new report.

The second Private Equity Value Report from Real Deals, in association with BDO, found 314 qualifying PE portfolio companies nationally and shortlisted 245 in its ranking.

Accountancy and business advisory firm BDO commissioned the research to understand the impact that private equity investment is having on the growth of the UK economy. The data was drawn from the most recent three years of accounts filed with Companies House.

Gavin Wood – CFO Spokesperson at Rosemont said: “It’s brilliant to be named in this ranking and recognised for our growth in recent years. Private equity investment has helped to unlock our potential as a business and we’re proud of all of our achievements over the last three years as we have continued to deliver against our mission to be a global supplier of novel delivery, patient-focused medicines”

Commenting on the research, BDO partner and UK head of Private Equity, Andrew Howson, said:

“The UK is home to many impressive private equity-backed businesses that are making a real impact. These companies are driving growth and have also shown remarkable resilience during challenging times. Their ability to adapt and thrive through periods of uncertainty highlights their strength and potential in the market, as well as the value creation benefits of private equity investment across the economy”

Find out more about the Private Equity Value Report here.